<?xml version='1.0' encoding='utf-8'?>
<dmn:definitions xmlns:dmn="https://www.omg.org/spec/DMN/20240513/MODEL/" namespace="http://smart.who.int/immunizations" name="IMMZ.D5.DT.Poliocontraindications" id="httpsmart.who.intimmunizationsdmnIMMZ.D5.DT.Poliocontraindications.dmn">
  <dmn:decision id="IMMZ.D5.DT.Poliocontraindications" name="IMMZ.D5.DT.Poliocontraindications">
    <dmn:decisionTable>
      <dmn:input id="input.Potentialcontraindications" label="Potential contraindications" />
      <dmn:rule id="rule.contra.IMMZ.D5.DT.Poliocontraindications.1">
        <dmn:inputEntry>
          <dmn:description>"Potential contraindications" = "Severe allergic reactions"</dmn:description>
          <dmn:text>The client has history of severe allergic reactions</dmn:text>
        </dmn:inputEntry>
        <dmn:inputEntry>
          <dmn:description>–</dmn:description>
          <dmn:text>–</dmn:text>
        </dmn:inputEntry>
        <dmn:outputEntry>
          <dmn:description>"Immunization recommendation status" = "Further evaluation needed"</dmn:description>
          <dmn:text>Poliovirus vaccination could be contraindicated. Clinical judgement required</dmn:text>
        </dmn:outputEntry>
        <dmn:annotationEntry>
          <dmn:text>–</dmn:text>
        </dmn:annotationEntry>
        <dmn:annotationEntry>
          <dmn:text>Polio vaccines: WHO position paper (June 2022) (4)</dmn:text>
        </dmn:annotationEntry>
        <dmn:outputEntry>
          <dmn:description>Do not vaccinate client with oral polio vaccine (OPV) if client has had a allergic reaction to OPV or to the trace antibiotics contained.</dmn:description>
          <dmn:text>Do not vaccinate client with inactivated polio vaccine (IPV) if client has had a previous severe reaction or known allergy to streptomycin, neomycin or polymyxin B.</dmn:text>
        </dmn:outputEntry>
        <dmn:annotationEntry>
          <dmn:text>–</dmn:text>
        </dmn:annotationEntry>
        <dmn:annotationEntry>
          <dmn:text>Polio vaccines: WHO position paper (June 2022) (4)</dmn:text>
        </dmn:annotationEntry>
      </dmn:rule>
      <dmn:rule id="rule.contra.IMMZ.D5.DT.Poliocontraindications.2">
        <dmn:inputEntry>
          <dmn:description>"Potential contraindications" = "Severely immunocompromised"</dmn:description>
          <dmn:text>The client is severely immunocompromised</dmn:text>
        </dmn:inputEntry>
        <dmn:outputEntry>
          <dmn:description>Clinical judgement is required if vaccination with IPV is considered
"Immunization recommendation status" =  "Contraindicated" (where "Type of poliovirus dose" = "bOPV") AND "Immunization recommendation status" = "Further evaluation needed" (where "Type of poliovirus dose" = "IPV")</dmn:description>
          <dmn:text>Poliovirus vaccination with bOPV is contraindicated</dmn:text>
        </dmn:outputEntry>
        <dmn:annotationEntry>
          <dmn:text>bOPV is contraindicated in severely immunocompromised patients with known underlying conditions. Such conditions include disorders of the thymus, symptomatic HIV infection or low CD4 T cell values, malignant neoplasm treated with chemotherapy, recent haematopoietic stem cell transplantation, drugs with known immunosuppressive or immunomodulatory properties (e.g. high-dose systemic corticosteroids, alkylating drugs, antimetabolites, TNFα inhibitors, IL-1 blocking agent or other monoclonal antibodies targeting immune cells), and current or recent radiation therapies targeting immune cells. These populations can safely receive IPV.</dmn:text>
        </dmn:annotationEntry>
        <dmn:outputEntry>
          <dmn:description>Check if vaccination with IPV is appropriate for the client, consider risks of vaccination and make a clinical judgement.</dmn:description>
          <dmn:text>For bOPV dose, do not vaccinate client for bOPV dose as bOPV vaccination is contranindicated in severely immunocompromised clients.</dmn:text>
        </dmn:outputEntry>
        <dmn:annotationEntry>
          <dmn:text>bOPV is contraindicated in severely immunocompromised patients with known underlying conditions. Such conditions include disorders of the thymus, symptomatic HIV infection or low CD4 T cell values, malignant neoplasm treated with chemotherapy, recent haematopoietic stem cell transplantation, drugs with known immunosuppressive or immunomodulatory properties (e.g. high-dose systemic corticosteroids, alkylating drugs, antimetabolites, TNFα inhibitors, IL-1 blocking agent or other monoclonal antibodies targeting immune cells), and current or recent radiation therapies targeting immune cells. These populations can safely receive IPV.</dmn:text>
        </dmn:annotationEntry>
      </dmn:rule>
      <dmn:rule id="rule.contra.IMMZ.D5.DT.Poliocontraindications.3">
        <dmn:inputEntry>
          <dmn:description>"Potential contraindications" = "Immunodeficiency syndromes"</dmn:description>
          <dmn:text>The client has immunodeficiency syndromes</dmn:text>
        </dmn:inputEntry>
        <dmn:outputEntry>
          <dmn:description>Clinical judgement is required if vaccination with IPV is considered
"Immunization recommendation status" =  "Contraindicated" (where "Type of poliovirus dose" = "bOPV") AND "Immunization recommendation status" = "Further evaluation needed" (where "Type of poliovirus dose" = "IPV")</dmn:description>
          <dmn:text>Poliovirus vaccination with bOPV is contraindicated</dmn:text>
        </dmn:outputEntry>
        <dmn:annotationEntry>
          <dmn:text>Individuals with primary immunodeficiency disorders should not be vaccinated with OPV and, instead, should receive IPV alone.</dmn:text>
        </dmn:annotationEntry>
        <dmn:outputEntry>
          <dmn:description>Check if vaccination with IPV is appropriate for the client, consider risks of vaccination and make a clinical judgement.</dmn:description>
          <dmn:text>For bOPV dose, do not vaccinate client for bOPV dose as bOPV vaccination is contranindicated in clients with immunodeficiency disorders.</dmn:text>
        </dmn:outputEntry>
        <dmn:annotationEntry>
          <dmn:text>Individuals with primary immunodeficiency disorders should not be vaccinated with OPV and, instead, should receive IPV alone.</dmn:text>
        </dmn:annotationEntry>
      </dmn:rule>
    </dmn:decisionTable>
  </dmn:decision>
</dmn:definitions>
